ROSSI, VIRGINIA
 Distribuzione geografica
Continente #
NA - Nord America 297
EU - Europa 293
AS - Asia 87
SA - Sud America 1
Totale 678
Nazione #
US - Stati Uniti d'America 295
RU - Federazione Russa 170
IT - Italia 36
IE - Irlanda 35
SG - Singapore 30
CN - Cina 22
SE - Svezia 18
HK - Hong Kong 14
CH - Svizzera 13
JO - Giordania 10
IN - India 9
FI - Finlandia 7
AT - Austria 3
DE - Germania 3
NO - Norvegia 3
CA - Canada 2
GB - Regno Unito 2
NL - Olanda 2
VN - Vietnam 2
BR - Brasile 1
LT - Lituania 1
Totale 678
Città #
Santa Clara 159
Dublin 35
Singapore 23
Chandler 14
Bern 13
Ashburn 12
Florence 12
Fairfield 9
Hong Kong 8
Beijing 7
Boardman 7
Helsinki 6
Houston 6
Woodbridge 5
Altamura 4
Lawrence 4
Mumbai 4
Pune 4
Seattle 4
Shanghai 4
Wilmington 4
Ann Arbor 3
Cambridge 3
Moscow 3
Oslo 3
Rome 3
Vienna 3
Boston 2
Buffalo 2
Hangzhou 2
Hillsboro 2
New York 2
Princeton 2
Venice 2
West Jordan 2
Bremen 1
Brescia 1
Chennai 1
Falkenstein 1
Falls Church 1
Lappeenranta 1
Munich 1
Ottawa 1
Recanati 1
Romola 1
Sulzano 1
Yubileyny 1
Totale 390
Nome #
A Machine Learning Decision Support System (DSS) for Neuroendocrine Tumor Patients Treated with Somatostatin Analog (SSA) Therapy 111
Retrospective analysis of 77 patients with ovarian cancer undergoing genetic testing for BRCA1 and BRCA2 mutations 108
Pembrolizumab for First-Line Treatment of Advanced Non-Small-Cell Lung Cancer: Analysis of Prognostic Factors of Outcomes 79
Gender matters. Sex-related differences in immunotherapy outcome in patients with non-small cell lung cancer 78
Castration-resistant prostate cancer with bone metastases: toward the best therapeutic choice 73
Analysis of molecular and clinical markers of resistance to bacillus of Calmette-Guérin immunotherapy in patients with urothelial non-muscle invasive bladder cancer 70
Association between Immune Related Adverse Events and Outcome in Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors 62
Bone Metastases in Renal Cell Carcinoma: Impact of Immunotherapy on Survival 56
Neutrophil-to-Eosinophil Ratio Predicts the Efficacy of Avelumab in Patients With Advanced Urothelial Carcinoma Enrolled in the MALVA Study (Meet-URO 25) 56
Totale 693
Categoria #
all - tutte 3.126
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.126


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202013 0 0 0 0 0 2 2 2 2 4 1 0
2020/202120 2 0 0 1 0 0 0 0 1 1 8 7
2021/202216 1 0 1 1 2 1 0 1 0 1 5 3
2022/2023125 3 13 3 9 7 25 16 13 16 1 4 15
2023/2024104 5 5 8 9 11 18 9 13 1 7 2 16
2024/2025409 17 52 35 107 137 61 0 0 0 0 0 0
Totale 693